Abstract:Background: This study aimed to investigate the feasibility, effectiveness, and safety of pancreatic duct stenting in managing acute biliary pancreatitis (ABP) necessitating endoscopic retrograde cholangiopancreatography (ERCP). It further aimed to provide valuable insights for subsequent clinical diagnosis and treatment. Methods: This research employs an observational retrospective case-control study design, encompassing patients with ABP who underwent ERCP at the hepatobiliary surgery department of the General Hospital of Ningxia Medical University between August 1, 2018, and December 31, 2020. A total of 229 cases were screened based on inclusion and exclusion criteria. Regardless of ABP severity, patients were categorized into the stent group (141) and the non-stent group (88). Changes in blood amylase (Amy), lipase (LIP), leukocyte count (WBC), total bilirubin (TBIL), alanine aminotransferase (ALT), hematocrit (HCT), and creatinine (CR) were compared between the two groups. Moreover, variables such as recovery time for oral feeding, hospitalization duration, hospitalization costs, local complications, systemic complications, and new organ failure were recorded to assess the therapeutic effect of pancreatic duct stenting. Results: No significant differences were observed in gender, age, Acute Physiology and Chronic Health Evaluation (APACHE) II score, ABP severity grade, organ failure (OF), cholangitis, or biliary obstruction between the pancreatic stent and non-stent groups (P > 0.05). There was no significant difference in the incidence of complications related to acute pancreatitis between the two groups (P > 0.05). The median fasting and hospitalization times of patients in the stent group were significantly shorter than those in the non-stent group (P < 0.05). No significant differences between the groups were observed in hospitalization costs and in-hospital mortality (P > 0.05). There were no significant variations in white blood cell (WBC) count, TBIL, ALT, and creatinine (Cr) at admission, 72 h, and in the differences between the two groups (P > 0.05). The levels of Amy at admission and 72 h in the stent group were significantly higher than those in the non-stent group (P < 0.05). The differences in LIP and HCT in the stent group were considerably higher than in the non-stent group (P < 0.05). Although no significant differences were observed in mean Amy and LIP between the two groups (P > 0.05), the mean 72-h HCT in the stent group was 38.39% (95% confidence interval [CI] 37.82%-38.96%) was lower than that in the non-stent group (39.44%, 95% CI 38.70-40.17%) (P < 0.05). Conclusion: In the stent group, feeding time and hospital stay were significantly shorter than those in the non-stent group. No significant differences were observed between the two groups in the incidence of complications and mortality. The HCT value decreased more rapidly in the stent group. Early pancreatic stent implantation demonstrated the potential to shorten the eating and hospitalization duration of patients with ABP, facilitating their prompt recovery. Trial registration: This study was registered as a single-center, retrospective case series (ChiCTR1800019734) at chictr.org.cn.

Sa1391 Endoscopic Pancreatic Sphincterotomy Combined with Pancreatic Duct Stent Can Effectively Prevent Recurrence of Acute Recurrent Pancreatitis Caused by Biliary Microlithiasis --- A Single-Center Study from Beijing, China

Clinical Outcomes of Endoscopic Pancreatic Sphincterotomy Combined with Pancreatic Duct Stenting for Acute Recurrent Pancreatitis Caused by Biliary Microlithiasis

Clinical research on the prophylactic effects of pancreatic duct stenting combined with non-storied anti-inflammatory drug on post endoscopic retrograde cholangiopancreatography pancreatitis in difficult bile duct cannulation

Pancreatic duct stent preventing post endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients

A retrospective analysis of the clinical efficacy of pancreatic duct stent implantation in the management of acute biliary pancreatitis requiring ERCP

A prospective study of pancreatic duct stent in preventing post-ERCP pancreatitis of difficult bile duct cannulation

Application of endoscopic sphincterotomy in acute pancreatitis with fluid collection: A prospective study

Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study

Impact of pancreatic and biliary stent on post-endoscopic papillectomy complications: A single-center retrospective study

Evaluation of Endoscopic Therapy in the Treatment of Acute Biliary Pancreatitis

Clinical Effect of Implantation of Pancreatic Duct Stent during ERCP in Prevention of Postoperative Pancreatitis

Application of Endoscopic Pancreatic Duct Stent Insertion in Chronic Pancreatitis: A Report of 30 Cases

Electrohydraulic lithotripsy through endoscopic retrograde cholangiopancreatography combined with SpyGlass in the treatment of complex pancreatic duct stones: A case report and literature review.

Emergancy Endoscopic Retrograde Cholangiopancreatography and Endoscopic Sphincterotomy for Acute Biliary Pancreatitis

Prevention of pancreatitis after endoscopic retrograde cholangiopancreatography with different methods:a Meta analysis

Etiology, clinical features and management of acute recurrent pancreatitis.

Endo-therapy of chronic pancreatitis:a clinical study of 296 patients

Application of Endoscopic Pancreatic Duct Stent Insertion: A Report of 20 cases

Endoscopic sphincterotomy to prevent post-ERCP pancreatitis in patients with biliary neoplasms: a multicenter retrospective cohort study

Endoscopic Diagnosis and Treatment of Chronic Pancreatitis in 17 Cases

Clinical Application of ERCP in Postoperative Pancreatitis Prevention for High-Risk Patients after Endoscopic Duct Stents